- 2025-09-27 12:14DPP-4-IN-10 1123219-12-4
- 2025-09-27 12:13DPP IV/hCA II-IN-1 2836996-95-1
- 2025-09-27 12:13DBPR108 1186426-66-3
- 2025-09-27 12:13Cetagliptin 2243737-33-7
- 2025-09-27 12:13Brensocatib (AZD7986) 1802148-05-5
- 2025-09-27 12:13AZD5248 1254318-44-9
- 2025-09-27 12:13Azaleatin 529-51-1
- 2025-09-27 12:13Antidiabetic agent 2
- 2025-09-27 12:12Vidofludimus hemicalcium (4sc-101 hemicalcium; SC12267 hemicalcium) 1354012-90-0
- 2025-09-27 12:122-Methoxy-5-acetoxy-fruranogermacr-1(10)-en-6-one 1809980-25-3
- 2025-09-27 12:12UCK2 Inhibitor-2 866842-71-9
- 2025-09-27 12:12(–)-Sitagliptin carbamoyl glucuronide 940002-59-5
- 2025-09-27 12:12RORγt/DHODH-IN-3 2764662-16-8
- 2025-09-27 12:12RORγt/DHODH-IN-2 2641758-86-1
- 2025-09-27 12:12RORγt/DHODH-IN-1 2764662-15-7
- 2025-09-27 12:12PfDHODH-IN-2 425629-94-3
- 2025-09-27 12:11Orludodstat (BAY-2402234) 2225819-06-5
- 2025-09-27 12:11ML390 2029049-79-2
- 2025-09-27 12:11Leflunomide-d4 (Leflunomide d4) 1189987-23-2
- 2025-09-27 12:11Indoluidin E 2763081-76-9
